Skip to main content
SpringerLink
Log in

Inhibition of human serum dopamineβ-hydroxylase after the oral administration of fusaric acid

  • Published:
Experientia Aims and scope Submit manuscript

Zusammenfassung

Die Dopamin-β-Hydroxylase-Aktivität im menschlichen Serum wurde nach der oralen Zufuhr von Fusarinsäure (50–300 mg) stark gehemmt.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. H. Hidaka, T. Nagatsu, K. Takeya, T. Takeuchi, H. Suda, K. Kojiri, M. Matsuzaki andH. Umezawa, J. Antibiot. Tokyo22, 228 (1966).

    Article  Google Scholar 

  2. T. Nagatsu, H. Hidaka, H. Kuzuya, K. Takeya, H. Umezawa, T. Takeuchi andH. Suda, Biochem. Pharmac.19, 35 (1970).

    Article  CAS  Google Scholar 

  3. K. Okamoto andK. Aoki, Jap. Circul. J.27, 282 (1963).

    Article  CAS  Google Scholar 

  4. I. Nagatsu, T. Nagatsu, K. Mizutani, H. Umezawa, M. Matsuzaki andT. Takeuchi, Nature Lond.230, 381 (1971).

    Article  CAS  Google Scholar 

  5. F. Terasawa andM. Kameyama, Jap. Circul. J.35, 339 (1971).

    Article  CAS  Google Scholar 

  6. R. Weinshilboum andJ. Axelrod, Circulation Res.28, 307 (1971).

    Article  CAS  Google Scholar 

  7. M. Goldstein, L. S. Freedman andM. Bonnay, Experientia27, 632 (1971).

    Article  CAS  Google Scholar 

  8. R. J. Connett andN. Kirshner, J. biol. Chem.245, 329 (1970).

    Article  CAS  Google Scholar 

  9. We thankDr. S. Udenfriend (Roche Institute of Molecular Biology, Nutley) for his stimulus to initiate this investigation, andDr. J. Axelrod (National Institutes of Health, Bethesda) for his personal information about the assay of serum dopamineβ-hydroxylase. We also wish to acknowledge the assistance of MissY. Sudo with the preparation of phenylethanolamine N-methyltransferase and the technical assistance of MissY. Nishikawa and MissY. Shibahara.

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry, School of Dentistry, Alchi-Gakuin University, Chikusa-ku, Nagoya, Japan

    T. Nagatsu, T. Kato, H. Kuzuya, T. Okada, H. Umezawa & T. Takeuchi

  2. Department of Neuropsychiatry, School of Medicine, Nagoya University, Showa-ku, Nagoya, Japan

    T. Nagatsu, T. Kato, H. Kuzuya, T. Okada, H. Umezawa & T. Takeuchi

  3. Institute of Microbial Chemistry, Shinagawa-ku, Tokyo, Japan

    T. Nagatsu, T. Kato, H. Kuzuya, T. Okada, H. Umezawa & T. Takeuchi

Authors
  1. T. Nagatsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Kato
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Kuzuya
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T. Okada
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. Umezawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. T. Takeuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nagatsu, T., Kato, T., Kuzuya, H. et al. Inhibition of human serum dopamineβ-hydroxylase after the oral administration of fusaric acid. Experientia 28, 779–780 (1972). https://doi.org/10.1007/BF01923125

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01923125

Keywords

Search

Navigation